Nancy Denyes - Net Worth and Insider Trading
Nancy Denyes Net Worth
The estimated net worth of Nancy Denyes is at least $18,914 dollars as of 2026-08-16. Nancy Denyes is the General Counsel of aTyr Pharma Inc and owns about 33,124 shares of aTyr Pharma Inc (ATYR) stock worth over $18,914. Details can be seen in Nancy Denyes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy Denyes has not made any transactions after 2026-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy Denyes
Nancy Denyes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy Denyes owns 1 companies in total, including aTyr Pharma Inc (ATYR) .
Click here to see the complete history of Nancy Denyes’s form 4 insider trades.
Insider Ownership Summary of Nancy Denyes
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2026-02-04 | General Counsel |
Nancy Denyes Latest Holdings Summary
Nancy Denyes currently owns a total of 1 stock. Nancy Denyes owns 33,124 shares of aTyr Pharma Inc (ATYR) as of February 4, 2026, with a value of $18,914.
Latest Holdings of Nancy Denyes
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2026-02-04 | 33,124 | 0.57 | 18,914 |
Holding Weightings of Nancy Denyes
Nancy Denyes Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy Denyes has made a total of 3 transactions in aTyr Pharma Inc (ATYR) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in aTyr Pharma Inc is the sale of 1,118 shares on February 4, 2026, which brought Nancy Denyes around $1,096.
Insider Trading History of Nancy Denyes
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Nancy Denyes Trading Performance
GuruFocus tracks the stock performance after each of Nancy Denyes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Denyes is -3.85%. GuruFocus also compares Nancy Denyes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Denyes within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nancy Denyes's insider trading performs compared to the benchmark.
Performance of Nancy Denyes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.03 | | | | | |
| Relative Return to S&P 500(%) | -21.01 | | | | | |
Nancy Denyes Ownership Network
Ownership Network List of Nancy Denyes
Ownership Network Relation of Nancy Denyes
Nancy Denyes Owned Company Details
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Nancy Denyes is the General Counsel of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , director & President and CEO Sanjay Shukla , and director & CEO and Executive Chairman John Mendlein .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Nancy Denyes made 1 insider transaction in aTyr Pharma Inc (ATYR) with a net sale of 1,118. Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 1,100,000 shares made by Paul Schimmel , a net purchase of 3,750 shares made by Jane A Gross , and a net sale of 3,745 shares made by Sanjay Shukla .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 100,000 shares, with a net purchase of 100,000 shares. During the past 18 months, 6,421 shares of aTyr Pharma Inc (ATYR) were sold and 1,103,750 shares were bought by its insiders, resulting in a net purchase of 1,097,329 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
Nancy Denyes Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy Denyes. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Nancy Denyes's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
